Literature DB >> 22289052

Sumatriptan inhibits TRPV1 channels in trigeminal neurons.

Miles Steven Evans1, Xiangying Cheng, Joseph A Jeffry, Kimberly E Disney, Louis S Premkumar.   

Abstract

OBJECTIVE: To understand a possible role for transient potential receptor vanilloid 1 (TRPV1) ion channels in sumatriptan relief of pain mediated by trigeminal nociceptors.
BACKGROUND: TRPV1 channels are expressed in small nociceptive sensory neurons. In dorsal root ganglia, TRPV1-containing nociceptors mediate certain types of inflammatory pain. Neurogenic inflammation of cerebral dura and blood vessels in the trigeminal nociceptive system is thought to be important in migraine pain, but the ion channels important in transducing migraine pain are not known. Sumatriptan is an agent effective in treatment of migraine and cluster headache. We hypothesized that sumatriptan might modulate activity of TRPV1 channels found in the trigeminal nociceptive system.
METHODS: We used immunohistochemistry to detect the presence of TRPV1 channel protein, whole-cell recording in acutely dissociated trigeminal ganglia (TG) to detect functionality of TRPV1 channels, and whole-cell recording in trigeminal nucleus caudalis (TNC) to detect effects on release of neurotransmitters from trigeminal neurons onto second order sensory neurons. Effects specifically on TG neurons that project to cerebral dura were assessed by labeling dural nociceptors with DiI.
RESULTS: Immunohistochemistry demonstrated that TRPV1 channels are present in cerebral dura, in trigeminal ganglion, and in the TNC. Capsaicin, a TRPV1 agonist, produced depolarization and repetitive action potential firing in current clamp recordings, and large inward currents in voltage clamp recordings from acutely dissociated TG neurons, demonstrating that TRPV1 channels are functional in trigeminal neurons. Capsaicin increased spontaneous excitatory postsynaptic currents in neurons of layer II in TNC slices, showing that these channels have a physiological effect on central synaptic transmission. Sumatriptan (10 µM), a selective antimigraine drug, inhibited TRPV1-mediated inward currents in TG and capsaicin-elicited spontaneous excitatory postsynaptic currents in TNC slices. The same effects of capsaicin and sumatriptan were found in acutely dissociated DiI-labeled TG neurons innervating cerebral dura.
CONCLUSION: Our results build on previous work indicating that TRPV1 channels in trigeminal nociceptors play a role in craniofacial pain. Our findings that TRPV1 is inhibited by the specific antimigraine drug sumatriptan, and that TRPV1 channels are functional in neurons projecting to cerebral dura suggests a specific role for these channels in migraine or cluster headache.
© 2012 American Headache Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289052      PMCID: PMC3342425          DOI: 10.1111/j.1526-4610.2011.02053.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  37 in total

1.  Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.

Authors:  M G Buzzi; M A Moskowitz
Journal:  Cephalalgia       Date:  1991-09       Impact factor: 6.292

2.  Superior sagittal sinus as a chronic venous route in the rat.

Authors:  J M Lipton
Journal:  J Appl Physiol       Date:  1972-05       Impact factor: 3.531

3.  Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase.

Authors:  I Jansen-Olesen; A Mortensen; L Edvinsson
Journal:  Cephalalgia       Date:  1996-08       Impact factor: 6.292

4.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor.

Authors:  M J Caterina; A Leffler; A B Malmberg; W J Martin; J Trafton; K R Petersen-Zeitz; M Koltzenburg; A I Basbaum; D Julius
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

5.  Expression of vanilloid receptor TRPV1 in the rat trigeminal sensory nuclei.

Authors:  Yong Chul Bae; Jung Min Oh; Se Jin Hwang; Yoshio Shigenaga; Juli G Valtschanoff
Journal:  J Comp Neurol       Date:  2004-10-04       Impact factor: 3.215

6.  Effects of sumatriptan on rat medullary dorsal horn neurons.

Authors:  E A Jennings; R M Ryan; M J Christie
Journal:  Pain       Date:  2004-09       Impact factor: 6.961

7.  Effects of sumatriptan on capsaicin-induced carotid haemodynamic changes and CGRP release in anaesthetized pigs.

Authors:  U Arulmani; J P C Heiligers; I M Garrelds; A Sánchez-López; E W Willems; C M Villalón; P R Saxena
Journal:  Cephalalgia       Date:  2004-09       Impact factor: 6.292

8.  mu-Opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat.

Authors:  T J Grudt; J T Williams
Journal:  J Neurosci       Date:  1994-03       Impact factor: 6.167

9.  Is myofascial pain of the temporal muscles relieved by oral sumatriptan? A cross-over pilot study.

Authors:  Thuan T T Dao; James P Lund; Guy Rémillard; Gilles J Lavigne
Journal:  Pain       Date:  1995-08       Impact factor: 6.961

10.  The site of pain origin during migraine attacks.

Authors:  J N Blau; S L Dexter
Journal:  Cephalalgia       Date:  1981-09       Impact factor: 6.292

View more
  17 in total

1.  Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy.

Authors:  Valerie B O'Leary; Marie O'Connell; Inga Antyborzec; Vasilis Ntziachristos; J Oliver Dolly; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 2.  Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered.

Authors:  Greg Dussor
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

3.  The complex actions of sumatriptan on rat dural afferents.

Authors:  Andrea M Harriott; Nicole N Scheff; Michael S Gold
Journal:  Cephalalgia       Date:  2012-06-18       Impact factor: 6.292

4.  Chronic itch development in sensory neurons requires BRAF signaling pathways.

Authors:  Zhong-Qiu Zhao; Fu-Quan Huo; Joseph Jeffry; Lori Hampton; Shadmehr Demehri; Seungil Kim; Xian-Yu Liu; Devin M Barry; Li Wan; Zhong-Chun Liu; Hui Li; Ahu Turkoz; Kaijie Ma; Lynn A Cornelius; Raphael Kopan; James F Battey; Jian Zhong; Zhou-Feng Chen
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

5.  The α6 subunit-containing GABAA receptor: A novel drug target for inhibition of trigeminal activation.

Authors:  Pi-Chuan Fan; Tzu-Hsuan Lai; Chia Chun Hor; Ming Tatt Lee; Pokai Huang; Werner Sieghart; Margot Ernst; Daniel E Knutson; James Cook; Lih-Chu Chiou
Journal:  Neuropharmacology       Date:  2018-07-21       Impact factor: 5.250

6.  Gi-coupled receptor activation potentiates Piezo2 currents via Gβγ.

Authors:  John Smith Del Rosario; Yevgen Yudin; Songxue Su; Cassandra M Hartle; Tooraj Mirshahi; Tibor Rohacs
Journal:  EMBO Rep       Date:  2020-03-29       Impact factor: 8.807

7.  Two TRPV1 receptor antagonists are effective in two different experimental models of migraine.

Authors:  Jannis E Meents; Jan Hoffmann; Sandra R Chaplan; Lars Neeb; Sigrid Schuh-Hofer; Alan Wickenden; Uwe Reuter
Journal:  J Headache Pain       Date:  2015-06-24       Impact factor: 7.277

Review 8.  TRP channels in COVID-19 disease: Potential targets for prevention and treatment.

Authors:  Sahar M Jaffal; Manal A Abbas
Journal:  Chem Biol Interact       Date:  2021-06-21       Impact factor: 5.192

9.  No relevant modulation of TRPV1-mediated trigeminal pain by intranasal carbon dioxide in healthy humans.

Authors:  Tim P Jürgens; Romy Reetz; Arne May
Journal:  J Headache Pain       Date:  2013-04-10       Impact factor: 7.277

10.  Over-expression of TRESK K(+) channels reduces the excitability of trigeminal ganglion nociceptors.

Authors:  Zhaohua Guo; Yu-Qing Cao
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.